As the opioid epidemic has continued to rage on, many strides have been made in the effort to preserve life and facilitate recovery. Part of that effort has been expanded access to FDA-approved medications to treat opioid use disorder, such as buprenorphine, methadone, and naltrexone, commonly referred to as MAT: Medication-Assisted Treatment. According to SAMHSA, MAT is “the use of medications, in combination with counseling and behavioral therapies to provide a ‘whole-patient’ approach to the treatment of substance use disorders. MAT has proved to be clinically effective and to significantly reduce the need for inpatient detoxification services.” (SAMHSA, 2022)